Proliferative mass observable
|
Neoplasm observable (observable entity)
Neoplasm observable
Tumor observable
Id
395531003
Status
Defined
Inheres in
Neoplasm
|
Additional pathologic finding in tumor specimen
Allred score for neoplasm
Anatomic location of neoplasm
6
Average intensity of positive staining neoplastic cells
Breast Imaging Reporting and Data System class
Clockface position of neoplasm
1
Degree of pigmentation of tumor
Diameter of primary neoplasm
Distance from anterior edge of tumor to limbus of cornea at cut edge, after sectioning
Distance of anterior margin of tumor base from limbus of cornea at cut edge, after sectioning
Distance of neoplasm to nipple
Distance of posterior margin of tumor base from edge of optic disc, after sectioning
Distance of tumor from anal verge
2
Distance of tumor from anorectal junction
Distance of tumor from mesorectal fascia
Distance of tumor from purse-string suture
Dukes stage
Edition of American Joint Commission on Cancer, Cancer Staging Manual used for TNM staging
FIGO stage for gynecological malignancy
6
Functional status of pancreatic endocrine tumor
Generic tumor extent
Histologic feature of neoplasm
6
Intergroup rhabdomyosarcoma study post-surgical clinical group
International neuroblastoma pathology classification
Length dimension of neoplasm
27
Linear extent of involvement of carcinoma
1
Location of malignant melanoma in specimen with involved deep margin
Location of malignant melanoma in specimen with uninvolved lateral margin
Location of melanoma in situ in specimen with uninvolved lateral margin
Location of tumor in relation to closest lateral margin
Location of tumor within eye
Location of tumor within lateral margin
Lymphoma extent of involvement
Modified Dukes stage
National Wilms Tumor Study Group Stage
2
Neoplasm weight
Nottingham mitotic count in primary malignant neoplasm of breast
Number fraction of estrogen receptors in neoplasm using immune stain
Number fraction of progesterone receptors in neoplasm using immune stain
Number of positive prostatic tissue chips obtained by resection
Number of tissue chips positive for carcinoma
Number of tumor nodules
Organ AND/OR tissue involved by tumor
3
Pathologic stage
1
Percentage of carcinoma in situ in neoplasm
Percentage of sarcomatoid element in tumor
Percentage of tumor involved by necrosis
Percentage span of neoplasm consisting of epithelium
Percentage span of neoplasm consisting of stroma
Peritoneal cancer index
Presence of direct invasion by neoplasm
3
Presence of ductal carcinoma in situ in epidermis of nipple
Proportion of specimen involved by tumor
1
Proportion score of neoplastic cells positive for hormone receptors using immunohistochemistry
Radial location of primary malignant neoplasm in excised breast specimen
Region of fallopian tube involved by tumor
Resectability of tumor
Residual cancer burden index
Residual tumor stage
Serum tumor marker category
Site involved by extension of neoplasm
1
Site of invasive ovarian tumor omental implant
Site of largest single mass
Site of non-invasive (desmoplastic) ovarian tumor omental implant
Site of non-invasive (epithelial) ovarian tumor omental implant
Stage of tumor involvement of non-regional lymph nodes
Status of adrenal gland involvement by tumor
Status of correlation between radiographic image and pathologic finding
Status of distant metastasis
2
Status of estrogen receptors of neoplasm
Status of intratumoral/peritumoral lymphocyte response
Status of invasive ovarian tumor omental implants
Status of non-invasive (desmoplastic) ovarian tumor omental implants
Status of non-invasive (epithelial) ovarian tumor omental implants
Status of ovarian tumor omental implants
Status of progesterone receptors of neoplasm
Status of regression of tumor
Status of renal sinus involvement by tumor
Status of residual neoplasm
2
Status of serum tumor marker level
Status of specimen involvement by macroscopic tumor
Status of specimen involvement by matted nodes
Status of specimen involvement by multifocal invasion
Status of specimen involvement by satellite nodule(s)
Status of tumor infiltration by lymphocytes
Status of tumor involvement by anaplasia
Status of tumor involvement by necrosis
1
Status of tumor metastasis to non-regional lymph nodes
Status of tumor metastasis to regional lymph nodes
TNM tumor observable
3
Tumor border behavior
Tumor configuration
2
Tumor extent of invasion, macroscopic
Tumor focality
1
Tumor immunophenotyping status
Tumor location after sectioning
Tumor nodule site
Tumor pigmentation
Tumor quantitation
4
Tumor stage
2
Tumor viability
Tumor volume
2
Type of polyp from which malignant neoplasm originated
Type of study performed on tumor specimen
WHO tumor classification
WHO tumor classification cannot be determined
